Ph1/2 Trial Of Navlimetostat With Pumitamig In MTAP-Deficient Advanced Non-Small Cell Lung Cancer
Clinical trial NCT07579221 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07579221
- Sponsor
- M.D. Anderson Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-11-30
- Primary completion
- 2029-08-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.